In March 1989, Angella Issajenko sat before the Dubin Inquiry in Toronto and wept on the stand, describing how angry she had grown in the months after Ben Johnson's September 1988 disqualification, hearing him deny ever knowingly taking a banned drug and let it be understood that if one had entered his body, his coach and his physician must have put it there without his knowledge. Issajenko told the inquiry a person did not turn on people who had done her a good turn. Commissioner Charles Dubin later wrote that he could not help feeling Johnson's public denials were among the factors that pushed her toward telling the whole truth about a decade of steroid use on Canada's Olympic sprint team, a story she and her coach had denied to anyone who asked for years.
The chemistry itself was not really in doubt by March 1989. The sample Johnson gave in Seoul had already shown, in the Medical Commission's own analysis, a pattern inconsistent with a single dose: long-term use, not one. What that chemistry could not do was say who had supplied it, or whether anyone else on the team had used steroids too. Charlie Francis, the team's coach, and Jamie Astaphan, its physician, had denied point-blank for years that any of their athletes used anabolic steroids, while Issajenko herself, testimony later established, used them through nine years of her career. None of those denials had ever cost the people making them anything; a reporter's question carries no penalty for a false answer, and a chemical reading of one body, however complete, cannot speak for anyone else's.
The inquiry that opened in Toronto on January 11, 1989, was a different kind of instrument. Ottawa created it by order-in-council on October 5, 1988, after Johnson himself asked for a public accounting of his own disqualification, under a federal statute, the Inquiries Act, that gives a commissioner the power to summon a witness and compel them to testify under oath with the same authority a civil court holds over a witness in a lawsuit. Over ninety-one days of hearings that ran into October, with dozens of lawyers in the room, Francis testified for eight days and Issajenko became the first athlete called to follow him. Once the two of them, after consulting their own lawyers, decided it was time to tell the commission the full story rather than continue the denials they had maintained for years, Dubin wrote that it was doubtful whether the other members of their circle would have come forward at all. By the time the hearings ended, forty-six Canadian athletes across a range of sports had admitted their own use of banned drugs to the same commission.
A chemical test can show repeated use in a single body. It cannot make a coach, a physician, or a teammate answer for what they did, because the sample in the lab belongs to one person, not to everyone who kept the same secret. What changed the outcome here was not a better test. It was the power to summon a person, under oath, into a room they could not simply decline to enter.
The sample taken in Seoul proved Ben Johnson had used steroids before, not just once. It took a sworn commission, and a teammate's loyalty to the two men he tried to blame, to say that he had not been alone.